Tag: CymaBay Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CymaBay Therapeutics Inc

CymaBay Therapeutics (NASDAQ:CBAY) Earns “Hold” Rating from HC Wainwright

Added to Collection on: 2020-02-02 22:37:30

Tags for this article:

Barclays
Clan Barclay
Companies
Life Sciences
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (CBAY) drops -3.87%, marking lose by bears

Added to Collection on: 2020-07-26 19:26:15

Tags for this article:

Finance
NASDAQ
Stock market
Stock
Financial economics
Financial markets
Short
Corporate finance
Equity securities
Financial ratios
Earnings per share
Initial public offering
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Adds 51.56% in a week: What's Lifting the Stock?

Added to Collection on: 2020-08-05 19:26:15

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Equity securities
Corporate finance
Financial regulation
Short
Stock
Initial public offering
NASDAQ
Share
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Short Interest Update

Added to Collection on: 2020-11-20 18:33:45

Tags for this article:

Finance
Financial markets
Money
Corporate finance
Stock
Stock market
Short
NASDAQ
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Drops -3.49% in a week: What's Hurting the Stock?

Added to Collection on: 2020-12-05 20:00:03

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Equity securities
Financial regulation
Short
Stock
NASDAQ
Initial public offering
Invesco
Share
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Consensus Rating of "Buy" from Analysts

Added to Collection on: 2020-12-12 06:15:59

Tags for this article:

Financial markets
Finance
Financial economics
Corporate finance
Stock
Stock market
Short
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Poised For Better Performance? CymaBay Therapeutics Inc. (CBAY) and Navient Corporation (NAVI)

Added to Collection on: 2021-03-03 13:30:00

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Navient
Corporate finance
Equity securities
Stock
Navi
NASDAQ
COMMODORE CAPITAL LP
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Expected to Announce Earnings of -$0.20 Per Share

Added to Collection on: 2021-03-06 07:55:05

Tags for this article:

Financial ratios
Finance
Economy
Money
Fundamental analysis
Price?earnings ratio
Earnings per share
ANGI Homeservices
BlackRock
Securities research
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors

Added to Collection on: 2021-04-05 12:00:00

Tags for this article:

Biotechnology
Life Sciences
Gilead Sciences
Pharmaceutical industry
United Therapeutics
CymaBay Therapeutics Inc
Janet Dorling

Click the tags to see associated articles and topics

View Article Details
CymaBay Names Lewis Stuart Chief Commercial Officer

Added to Collection on: 2021-05-10 12:00:00

Tags for this article:

Life Sciences
Biotechnology
Roivant Sciences
Biopharmaceutical
Prostate cancer
CymaBay Therapeutics Inc
Lewis Stuart

Click the tags to see associated articles and topics

View Article Details
Book a Demo